Musculoskeletal Chronic Graft versus Host Disease-A Rare Complication to Allogeneic Hematopoietic Stem Cell Transplant: A Case-Based Report and Review of the Literature.
Alexander Dåtland KvingeTobias KvammenHrvoje MileticLaurence Albert BindoffHåkon ReikvamPublished in: Current oncology (Toronto, Ont.) (2022)
Musculoskeletal graft versus host disease (GVHD) is a rare manifestation of chronic GVHD (cGVHD) following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Left untreated, the disease can cause extensive damage to muscle tissue and joints. We describe a 62-year-old male with musculoskeletal GVHD and generalized muscle pain and stiffness. In addition, we performed a systemic literature review based on published cases of musculoskeletal GVHD between 1983 and 2019. We identified 85 cases, 62% male and 38% female with an age of 4-69 years and median age of 39 years at diagnosis. The majority of patients (72%) also had manifestations of cGVHD in at least one other organ system, most frequently the skin (52%), followed by oropharyngeal mucosa (37%), and pulmonary and gastrointestinal tract (GI tract) (21%). We conclude that, while musculoskeletal cGVHD is a rare complication of allo-HSCT, it remains a serious and debilitating risk that must be considered in patients with muscle pain, muscle weakness, joint stiffness, and tissue inflammation. Early intervention is critical for the patient's prognosis.
Keyphrases
- allogeneic hematopoietic stem cell transplantation
- hematopoietic stem cell
- acute myeloid leukemia
- acute lymphoblastic leukemia
- skeletal muscle
- chronic pain
- end stage renal disease
- case report
- oxidative stress
- randomized controlled trial
- chronic kidney disease
- ejection fraction
- neuropathic pain
- newly diagnosed
- pulmonary hypertension
- low dose
- systematic review
- bone marrow
- drug induced
- patient reported outcomes
- soft tissue